NCT06694792View on ClinicalTrials.gov

Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst BIomarkers Detection (INCITE) Consortium

Not yet recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
IPMN, Pancreatic
All Listed Sponsors
collaborator

University of Pisa

OTHER

collaborator

Casa Sollievo della Sofferenza IRCCS

OTHER

collaborator

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

OTHER

lead

IRCCS San Raffaele

OTHER

NCT06694792 - Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst BIomarkers Detection (INCITE) Consortium | Biotech Hunter | Biotech Hunter